Trial Profile
Addition of paclitaxel to anthracycline-based adjuvant or neoadjuvant treatment in women with operable breast cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 May 2013
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Cyclophosphamide; Doxorubicin; Fluorouracil; Methotrexate
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms ECTO
- 04 Jun 2013 Results at 10 years presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 05 Nov 2010 New trial record.